Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Open accessThe DOI matches its Crossref record; 198 of the 206 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is a predominant malignancy worldwide, being the fourth most common cause of mortality and morbidity. The CRC incidence in adolescents, young adults, and adult populations is increasing every year. In the pathogenesis of CRC, various factors are involved including diet, sedentary life, smoking, excessive alcohol consumption, obesity, gut microbiota, diabetes, and genetic mutations. The CRC tumor microenvironment (TME) involves the complex cooperation between tumoral cells with stroma, immune, and endothelial cells. Cytokines and several growth factors (GFs) will sustain CRC cell proliferation, survival, motility, and invasion. Epidermal growth factor receptor (EGFR), Insulin-like growth factor -1 receptor (IGF-1R), and Vascular Endothelial Growth Factor -A (VEGF-A) are overexpressed in various human cancers including CRC. The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) and all the three major subfamilies of the mitogen-activated protein kinase (MAPK) signaling pathways may be activated by GFs and will further play key roles in CRC development. The main aim of this review is to present the CRC incidence, risk factors, pathogenesis, and the impact of GFs during its development. Moreover, the article describes the relationship between EGF, IGF, VEGF, GFs inhibitors, PI3K/AKT/mTOR-MAPK signaling pathways, and CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Increased levels of cytokines and growth factors in the TME can activate cell proliferation and survival signaling pathways in CRC cells (e.g., MAPK and PI3K/AKT) [84].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lin, X., Wang, S., Sun, M., Zhang, C., Wei, C., Yang, C., Dou, R., Liu, Q., & Xiong, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0708-7 · Cited by 207
RetractedZhang, D., Qiu, X., Li, J., Zheng, S., Li, L., & Zhao, H. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1556064 · Cited by 72
RetractedBrenner, H., Kloor, M., & Pox, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61649-9 · Cited by 2,762
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Colorectal cancer statistics, 2014
Siegel, R., DeSantis, C., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,562
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Kuipers, E. J., Grady, W. M., Lieberman, D., Seufferlein, T., Sung, J. J., Boelens, P. G., van de Velde, C. J. H., & Watanabe, T. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.65 · Cited by 1,563
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
The MAPK signalling pathways and colorectal cancer
Fang, J. Y., & Richardson, B. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70168-6 · Cited by 1,185
Microsatellite Instability in Colorectal Cancer-the Stable Evidence
Vilar, E., & Gruber, S. B. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.237 · Cited by 1,063
Research works printed but not linked: 1
- Haraldsdottir, 2014, Colorectal cancer—Review, Laeknabladid, 100, 75
Cited by
Items 401–436 of 436
Anand, R., Kaliyamoorthy, S., Boopathy, V., Ramasamy, J., & Sambandam, R. (2026) · Exploration of Immunology · doi:10.37349/ei.2026.1003252
Regulation of autophagy by the p53 family and the implications for cancer therapies
Hsin, I.-L., Chen, C.-C., Sung, Y.-T., Lien, C., Shih, Y., Wu, K.-Y., Wu, T.-Y., Yeh, F.-Y., Lin, Y.-R., Hsu, Y.-C., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-05143-5
“Interestingly, several growth factors exert an inhibitory effect on autophagy by activating mTOR through the PI3K/Akt and Ras/Raf/ MEK/ERK signaling cascades [22].”
Gao, P., Feng, W., Zhao, X., Shen, J., Wang, X., Wu, X., Zhou, W., Wang, Y., Chen, J., & An, W. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504092
Setiawan, F., Setiawan, W. A., Situmeang, R., Ambarwati, Y., Juliasih, N. L. G. R., Susianti, S., Ahmadi, P., Arai, M., & Setiawan, A. (2026) · Journal of Multidisciplinary Applied Natural Science · doi:10.47352/jmans.2774-3047.441
DARAMA, G., Bora, Ö., Bostanci, F., Mehdizadehtapeh, L., ÖZTÜRK, S. A., Tekiner, İ. H., & Abdik, H. (2026) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2026.27.6.2175
“In literature, some in vitro studies mainly focused on blocking AKT, NF-KB and CCND1 for preventing colon cancer [46, 47], aligning with our work.”
Polyphenols and tissue regeneration in wound healing
Akhtar, B., Noor, S., Iram, G., Iqbal, D. M. A., Nazari, M., Nowaczyk, A., Fijałkowski, Ł., & Kaleem, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45193-5.00013-2
Jeon, J., Jang, J., Moon, C. Y., Lee, J., Hong, V. S., Kang, H., Park, J. T., Heo, N. H., Park, J. T., Park, J., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19070985
Abbas, A., Vohra, S., Weiskirchen, R., Mushtaq, H., Amjad, A., Tabassum, A., Zafar, S., Chaudhary, A. A., Alhudhaibi, A. M., & Pandey, B. (2026) · Pharmaceuticals · doi:10.3390/ph19071036
“However, this regulatory mechanism is highly context-dependent and reversible, reflecting the dynamic nature of intracellular redox signaling [8].”
Network pharmacology and molecular simulation suggest potential mechanisms of sorafenib-induced HFSR
Wang, L. Q. (2026) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps.2026.39.10.272.1
Wu, Y.-L., Bai, H., Jiang, C., Zhang, Y., Liu, W., Hang, J., & Huang, Y. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71275
Rahman, N. L. A. (2023) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)
Khan, M. M., Hossain, M. A., Hossain, M. S., Gupta, D. D., Showrov, N. A., & Parvin, S. (2026) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2026.111854
Liu, Y., Siegfried, G., Pernot, S., He, Z., Martín-Bórnez, M., Tejpar, S., Castanet, F., Desolneux, G., Évrard, S., Steinmetzer, T., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03875-w
Micheletti, S., Fanfani, V., Vogt, J. E., Quackenbush, J. F., Fischer, J., Marx, A., & Mandros, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.15.738791
“The ErbB signaling pathway–which is crucial for the regulation of cell proliferation, migration, and apoptosis–influences LIHC progression and intersects with the PI3K/Akt, JAK/STAT, and MAPK pathways [Ho et al., 2017,Stefani et al., 2021].”
Duan, J., Jiang, R., Yuan, L., Xu, X., & Sun, D. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-10122-5
“Enrichment of the Ras pathway in GSEA further supports this model, demonstrating that PGF concurrently stimulates downstream PI3K/AKT and MAPK/ERK signaling via the VEGFR1-Ras axis to assemble a coordinated pro-survival network [39, 40].”
Ardinata, D., Alferraly, T. I., Yosi, A., & Pase, M. A. (2026) · PubMed Central · doi:10.30476/ijms.2025.106644.4091
Fu, Z., Hu, Z., Jin, H., & Yin, S. (2026) · Toxics · doi:10.3390/toxics14080705
“Cellular proliferation, growth, and survival are critically regulated by the PI3K/AKT signaling pathway, and its dysregulation is frequently implicated in colorectal carcinogenesis [47,48].”
Świerczyński, M., Makaro, A., Jaczynska, M., Sobalska‐Kwapis, M., Seweryn, M., Kasprzak, Z., Tarasiuk, A., & Sałaga, M. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00887-x
Metilda Stella Rani, G., Dinesh, C., Kaushik Shankar, A., Sarmilan, K., K, S. S., & Yuvamitha, A. (2026) · International Journal of Research in Pharmacology & Pharmacotherapeutics · doi:10.61096/ijrpp.v15.i3.2026.1156-1168
Synthetic Heparan Sulfate-like Oligosaccharides as Tools to Decipher Growth Factor Recognition
Wakpal, J., Singh, K., Hotor, M., Philip, L., Yost-Slinker, D., Wang, J., Abdulsalam, H., & Nguyen, H. M. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00760
Ge, Y., Qian, L., Jiang, W., Zheng, L., Wang, J., Feng, M.-K., Zhu, Y., Wang, M.-J., Sun, S.-S., 芮景, et al. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.123706
Nehdi, S., Aldahmash, W., Al-Hazmi, A., Feriani, A., Jalouli, M., Alhelaisi, A., Shaik, J. P., Alwasel, S. H., & Harrath, A. H. (2026) · Physiological Research · doi:10.33549/physiolres.935737
“The PI3K/AKT/mTOR and AMPK signaling pathways are essential for controlling cellular growth, metabolism, and survival [60].”
Lee, J., Hur, J., & Choi, H. (2026) · Journal of Medicinal Food · doi:10.1177/1096620x261481638
Fang, W.-J., Zhang, Y., Zhang, J., Zhang, T., & Zhang, X. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1909880
“Previous research reported that Tregs can inhibit the functions of CD8 + T cells and NK cells by secreting IL-10 and TGF-b (67), whereas Th2 cells promote the M2 polarization of macrophages through the IL-4/IL-13 signaling pathway, thereby attenuating antitumor immune responses (68).”
Chang, L., Kang, Y., Zhu, M., Liu, J., Lan, C., & Xu, Q. (2026) · PLoS ONE · doi:10.1371/journal.pone.0350571
“PIK3CA is one of the most frequently altered genes in cervical cancer [11,12], and its activation promotes tumor-cell proliferation, survival, migration, and treatment resistance through the PI3K/Akt/mTOR signaling pathway [15,16].”
Jiang, Y., Zhao, D., Liao, D., Yang, F., Lin, C., Liu, P., Chen, Z., Fang, S., Deng, X., Ni, X., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03995-3
“I), suggesting that ACTB contributes to cell cycle progression and proliferative activity in ESCC tumors.”
Amos, Y., Nsengimaana, B., Faleyimu, M. B., Olorundunsi, A. P., Lawal, A. A., Kenou, O. M., Martin, D. R., Jawali, A., & Awe, O. I. (2026) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-026-00840-0
“Alterations in the APC gene activate the Wnt/β-catenin signaling cascade, leading to unregulated cell propagation [11], while dysregulation of the PI3K/ AKT/mTOR, MAPK/ERK, and p53/Bcl-2 cascades promote survival and confer apoptosis resistance [12–14].”
PENGARUH OBESITAS DAN AKTIVITAS FISIK TERHADAP RISIKO KANKER KOLOREKTAL DI INDONESIA
Andini, R. D., Aghna, S., Farrazafir, N. B., Izzah, S., Nafisah, L., & Sistiarani, C. (2025) · Jurnal Kesehatan Tambusai
Zare, E., Saghaei, M., Mosallaei, M., Mehrad‐Majd, H., & Namdar, A. B. (2026) · Advanced Biomedical Research · doi:10.4103/abr.abr_481_25
“[27,30] The overexpression of IGF2 due to LOI not only stimulates tumor growth but also leads to reduced chemosensitivity and immune evasion, resulting in a more aggressive clinical phenotype.”
Pascu, A., Ianole, V., & Danciu, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209346
“The biological functions of this pathway highlight its crucial role in tumor initiation and progression [44,45] and treatment resistance [46,47].”
Shi, C., Chen, Y., Hu, X., Jin, F., Liu, Q., Ou, C., & Lu, Y. (2026) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.70200
Khan, A., Saher, L., Ceballos, M. W. G., & Malak, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-49074-3.00011-x
Zhao, K., Meyer, L., Braun, M., Otte, K., Bitter, C., Pawlik, M., Raifer, H., Helmprobst, F., Pagenstecher, A., Urban, H., et al. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70357
“Mechanistically, receptor tyrosine kinase signaling activates PI3K, which converts PIP2 into PIP3 [15,16], leading to activation of AKT isoforms (AKT1 – 3) [17 – 19].”
Metadata
- Authors
- Stefani, C., Miricescu, D., Stanescu-Spinu, I.-I., Nica, R. I., Greabu, M., Totan, A. R., & Jinga, M.
- Affiliations
- Department of Family Medicine and Clinical Base, ‘‘Dr. Carol Davila’ Central Military Emergency University Hospital, 051075 Bucharest, Romania
- Carol Davila University of Medicine and Pharmacy (RO)
- Department of Biochemistry, Faculty of Dental Medicine, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd, 050474 Bucharest, Romania
- Spitalul Universitar de Urgenţă Militar Central Dr. Carol Davila (RO)
- Corresponding author
- Miricescu, Daniela
- Greabu, Maria
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-09-23
- Volume
- 22
- Issue
- 19
- Pages
- 10260
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8508474
- OpenAlex
- W3200117713
- Cited by
- 402
- References
- 206
- Citations by year
- 2026: 69 · 2025: 134 · 2024: 103 · 2023: 68 · 2022: 26 · 2021: 2
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- colorectal cancer, growth factors, PI3K/AKT/mTOR pathway, MAPK signaling, tumor microenvironment, EGFR, IGF-1 receptor, VEGF-A, growth factor inhibitors, colorectal cancer risk factors, colorectal cancer pathogenesis, cell proliferation and invasion
- MeSH terms
- Animals, Humans, Colorectal Neoplasms, Signal Transduction, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Intercellular Signaling Peptides and Proteins, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

